Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:17 pm Sale |
2024-12-31 | 13G | ProMIS Neurosciences, Inc. PMN |
Armistice Capital, LLC | 2,509,977 7.680% |
-160,023 (-5.99%) |
Filing History |
| 2025-02-14 5:17 pm Purchase |
2024-12-31 | 13G | Palisade Bio, Inc. PALI |
Armistice Capital, LLC | 285,417 9.990% |
159,725 (+127.08%) |
Filing History |
| 2025-02-14 5:15 pm Purchase |
2024-12-31 | 13G | Organovo Holdings, Inc. ONVO |
Armistice Capital, LLC | 141,724 9.990% |
20,053 (+16.48%) |
Filing History |
| 2025-02-14 5:15 pm Sale |
2024-12-31 | 13G | Orthofix Medical Inc. OFIX |
Armistice Capital, LLC | 3,000,000 7.850% |
-768,000 (-20.38%) |
Filing History |
| 2025-02-14 5:14 pm Purchase |
2024-12-31 | 13G | Nevro Corp. NVRO |
Armistice Capital, LLC | 3,736,000 9.970% |
8,000 (+0.21%) |
Filing History |
| 2025-02-14 5:13 pm Purchase |
2024-12-31 | 13G | NanoVibronix, Inc. NAOV |
Armistice Capital, LLC | 349,284 9.990% |
42,665 (+13.91%) |
Filing History |
| 2025-02-14 5:11 pm Unchanged |
2024-12-31 | 13G | Mural Oncology plc MURA |
Armistice Capital, LLC | 1,700,000 9.960% |
0 (Unchanged) |
Filing History |
| 2025-02-14 5:08 pm Sale |
2024-12-31 | 13G | ASPIRA WOMENS HEALTH INC N AWHL |
Armistice Capital, LLC | 800,797 4.990% |
-455,203 (-36.24%) |
Filing History |
| 2025-02-14 5:08 pm Sale |
2024-12-31 | 13G | Presidio Property Trust, Inc. SQFT |
Armistice Capital, LLC | 75,653 4.990% |
-85,630 (-53.09%) |
Filing History |
| 2025-02-14 5:07 pm Unchanged |
2024-12-31 | 13G | Rekor Systems, Inc. REKR |
Armistice Capital, LLC | 2,850,000 2.950% |
0 (Unchanged) |
Filing History |
| 2025-02-14 5:07 pm Sale |
2024-12-31 | 13G | Avinger, Inc. AVGR |
Armistice Capital, LLC | 278,769 4.990% |
-25,242 (-8.30%) |
Filing History |
| 2025-02-14 5:06 pm Unchanged |
2024-12-31 | 13G | Protagenic Therapeutics, Inc. PTIX |
Armistice Capital, LLC | 17,143 3.410% |
0 (Unchanged) |
Filing History |
| 2025-02-14 5:06 pm Purchase |
2024-12-31 | 13G | Neuphoria Therapeutics Inc. NEUP |
Armistice Capital, LLC | 1,033,796 4.990% |
1,033,796 (New Position) |
Filing History |
| 2025-02-14 5:05 pm Sale |
2024-12-31 | 13G | Aurinia Pharmaceuticals Inc. AUPH |
Armistice Capital, LLC | 6,400,000 4.470% |
-1,800,000 (-21.95%) |
Filing History |
| 2025-02-14 5:04 pm Purchase |
2024-12-31 | 13G | XORTX Therapeutics Inc. XRTX |
Armistice Capital, LLC | 346,807 9.990% |
177,017 (+104.26%) |
Filing History |
| 2025-02-14 5:01 pm Purchase |
2024-12-31 | 13G | Wearable Devices Ltd. WLDS |
Armistice Capital, LLC | 91,589 9.990% |
91,589 (New Position) |
Filing History |
| 2025-02-14 5:01 pm Purchase |
2024-12-31 | 13G | Verrica Pharmaceuticals Inc. VRCA |
Armistice Capital, LLC | 9,134,817 9.990% |
9,134,817 (New Position) |
Filing History |
| 2025-02-14 5:01 pm Sale |
2024-12-31 | 13G | Avenue Therapeutics, Inc. ATXI |
Armistice Capital, LLC | 100,400 4.990% |
-14,600 (-12.70%) |
Filing History |
| 2025-02-14 4:58 pm Sale |
2024-12-31 | 13G | Assembly Biosciences, Inc. ASMB |
Armistice Capital, LLC | 316,084 4.990% |
-37,916 (-10.71%) |
Filing History |
| 2025-02-14 4:57 pm Sale |
2024-12-31 | 13G | Aptose Biosciences Inc. APTO |
Armistice Capital, LLC | 34,176 4.990% |
-30,998 (-47.56%) |
Filing History |